Collaborations

Spheromics is proud to collaborate with

Inselspital Bern, SwitzerlandInselspital Bern, Switzerland

Novartis Pharma AG, SwitzerlandNovartis Pharma AG, Switzerland

FDA (Food and Drug Administration, USA)FDA (Food and Drug Administration, USA)

University of British Columbia, BCUniversity of British Columbia, BC

Hannover Medical School, GermanyHannover Medical School, Germany

Andreas Scherer is member of the MAQC-II, a FDA-driven intitiative for microarray quality control
Andreas Scherer is member of the MAQC-II ”Batch Effect Removal Team”